Product
Pramipexole ER
1 clinical trial
2 indications
Indication
Parkinson's diseaseIndication
Parkinson's DiseaseClinical trial
A Phase 3, Twelve-week Study to Determine the Efficacy, Safety and Tolerability of P2B001 Once Daily Compared to Its Individual Components in Subjects With Early Parkinson's Disease and to a Calibration Arm of Pramipexole ER.Status: Completed, Estimated PCD: 2021-08-23